# Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT

> **NCT00718354** · PHASE3 · COMPLETED · sponsor: **Thrombosis Research Institute** · enrollment: 740 (actual)

## Conditions studied

- Gastric Cancer
- Gastroesophageal Cancer

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** Standard Chemotherapy

## Key facts

- **NCT ID:** NCT00718354
- **Lead sponsor:** Thrombosis Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-01
- **Final completion:** 2010-08
- **Target enrollment:** 740 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718354, "Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00718354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*